Twist Bioscience Corp (TWST) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Twist Bioscience Corp (TWST) has a cash flow conversion efficiency ratio of 0.003x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.11 Million) by net assets ($445.74 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see TWST stock market capitalisation for the company's overall valuation and market capitalisation.
Twist Bioscience Corp - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Twist Bioscience Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Twist Bioscience Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Twist Bioscience Corp ranked by their cash flow conversion efficiency. Explore how high is Twist Bioscience Corp's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CITIC Securities Company Limited
F:CI9
|
0.221x |
|
Viavi Solutions Inc
NASDAQ:VIAV
|
-0.031x |
|
CITIC Metal Co. Ltd. A
SHG:601061
|
N/A |
|
Vietnam Prosperity Joint Stock Commercial Bank
VN:VPB
|
0.065x |
|
Hindustan Petroleum Corporation Limited
NSE:HINDPETRO
|
0.291x |
|
Shanghai International Airport Co Ltd
SHG:600009
|
0.041x |
|
Alstom S.A.
PA:ALO
|
-0.053x |
|
Lotus Bakeries
BR:LOTB
|
0.090x |
Annual Cash Flow Conversion Efficiency for Twist Bioscience Corp (2016–2025)
The table below shows the annual cash flow conversion efficiency of Twist Bioscience Corp from 2016 to 2025. View TWST stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $472.96 Million | $-47.63 Million | -0.101x | +25.73% |
| 2024-09-30 | $472.69 Million | $-64.09 Million | -0.136x | +40.67% |
| 2023-09-30 | $623.43 Million | $-142.47 Million | -0.229x | -45.03% |
| 2022-09-30 | $789.38 Million | $-124.39 Million | -0.158x | +18.46% |
| 2021-09-30 | $580.82 Million | $-112.24 Million | -0.193x | +54.32% |
| 2020-09-30 | $336.26 Million | $-142.25 Million | -0.423x | +26.84% |
| 2019-09-30 | $152.08 Million | $-87.94 Million | -0.578x | -276.03% |
| 2018-09-30 | $-201.42 Million | $-66.16 Million | 0.328x | -14.61% |
| 2017-09-30 | $-133.36 Million | $-51.30 Million | 0.385x | -23.63% |
| 2016-09-30 | $-76.61 Million | $-38.59 Million | 0.504x | -- |
About Twist Bioscience Corp
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo … Read more